Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Pediatr Dermatol ; 35(1): e35-e38, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29243307

RESUMEN

Superficial granulomatous pyoderma gangrenosum, a rare variant of pyoderma gangrenosum, has been considered to be the most benign form of the disease. We present the case of a 15-year-old boy with pulmonary involvement and nodular scleritis associated with this unusual type of pyoderma gangrenosum and discuss its differential diagnosis.


Asunto(s)
Pulmón/patología , Piodermia Gangrenosa/complicaciones , Escleritis/complicaciones , Adolescente , Biopsia , Ciclofosfamida/uso terapéutico , Diagnóstico Diferencial , Glucocorticoides/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Masculino , Piodermia Gangrenosa/tratamiento farmacológico , Escleritis/tratamiento farmacológico , Piel/patología
3.
J Child Neurol ; 25(8): 1034-7, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20350966

RESUMEN

Pompe disease or glycogen-storage disease type 2 (GSD2, OMIM 232300) is an autosomal recessive disorder caused by mutations in the acid alpha-glucosidase gene. Late-onset GSD2 resembles some limb-girdle and Becker muscular dystrophies. The screening of GSD2 through the measurement of acid alpha-glucosidase activity in dried blood spots was applied to a selected sample of 5 Mexican patients with proximal myopathies of unknown etiology. Only 1 male patient showed a low level of acid alpha-glucosidase activity and a compound heterozygote genotype for the c.-32-13T>G splicing mutation present in most white late-onset Pompe disease cases and the novel mutation p.C558S. To our knowledge, this is the first report of a Mexican patient with late-onset GSD2. The identification of c.-32-13T>G in our patient could reflect the genetic contribution of European ancestry to the Mexican population. The enzymatic screening of GSD2 could be justified in patients with myopathies of unknown etiology.


Asunto(s)
Enfermedad del Almacenamiento de Glucógeno Tipo II/enzimología , Enfermedad del Almacenamiento de Glucógeno Tipo II/genética , Enfermedades Musculares/enzimología , Enfermedades Musculares/genética , Mutación/genética , alfa-Glucosidasas/genética , Adolescente , Edad de Inicio , Femenino , Predisposición Genética a la Enfermedad/genética , Pruebas Genéticas/métodos , Genotipo , Enfermedad del Almacenamiento de Glucógeno Tipo II/fisiopatología , Humanos , Masculino , México/etnología , Enfermedades Musculares/fisiopatología , Población Blanca/etnología , Población Blanca/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA